• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

New imaging technique gives clearer picture of stroke damage

, 26 August 2020/in E-News /by 3wmedia

According to the American Heart Association, ischemic strokes account for nearly 90 percent of all strokes. They occur when a blocked artery prevents blood from getting to the brain and usually result in long-term disability or death. Now, a team of researchers led by the University of Missouri School of Medicine has developed a new, real-time method of imaging molecular events after strokes ― a finding that may lead to improved care for patients.

‘During an ischemic stroke, harmful enzymes called gelatinase become overactive in areas of the brain where blood flow is cut off, said Zezong Gu, PhD, an associate professor of pathology and anatomical sciences at the MU School of Medicine and lead author of the study. ‘Over-activation of these enzymes causes brain damage. Our team hypothesized that if we could visualize and track this activity in real-time, we could then work on developing a way to block the activity and prevent brain damage from occurring.’

Magnetic resonance imaging (MRI) is commonly used to diagnose strokes because it produces precise, sectional images of the brain. Although these images can verify the region of arterial blockages within the brain, current contrast agents are not specific or sensitive enough to reveal important molecular events, such as gelatinase activity, on an MRI image.

To overcome this obstacle, the researchers used peptides that specifically recognize gelatinase activity. The peptides were tagged with contrast agents through a process developed by research team member Roger Tsien, PhD, a biochemist and Nobel Laureate at the University of California, San Diego.

‘Once the tagged peptides travelled to the site of increased gelatinase activity, they were absorbed into the cells with this activated enzyme,’ Gu said. ‘When enough of these peptides were absorbed, the stroke site was visible on an MRI. We tested this technique in both cell-based and mouse models of ischemic stroke. Using this method, we successfully tracked gelatinase activity.’

Gu suggests that real-time imaging of this activity could lead to a better understanding of how to treat strokes and mediate the damage they cause.

‘Our findings indicate that tagged peptides can be used as a non-invasive probe to detect and track gelatinase activity,’ Gu said. ‘This process may serve as an additional tool for clinicians to treat their patients if a viable inhibitor can be developed to prevent the damage caused by this activity.’

Gu and his team currently are working to develop such a gelatinase inhibitor. University of Missouri

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:39New imaging technique gives clearer picture of stroke damage

Low-grade brain tumours radiation plus chemotherapy is best treatment

, 26 August 2020/in E-News /by 3wmedia

New clinical-trial findings show that patients with a low-grade form of brain cancer who are treated with radiation plus a combination of chemotherapy drugs have better survival than patients treated with radiation alone.

The study comes from a randomized phase III clinical trial of 251 people with grade 2 gliomas, tumours that occur mostly in young adults and cause progressive neurological problems and premature death. Researchers at The Ohio State University Comprehensive Cancer Center

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:34Low-grade brain tumours radiation plus chemotherapy is best treatment

Patient studies underway for CBCT

, 26 August 2020/in E-News /by 3wmedia

Carestream is expanding into new imaging modalities, including cone beam CT, and key advances were demonstrated at the recent British Orthopaedic Association (BOA) Annual Congress conference held in Liverpool, UK, where a conceptual scale model of cone beam CT was on display.
Patient studies are helping to guide Carestream’s development of cone beam CT (CBCT) systems for orthopedic imaging at hospitals, clinics and sports medicine providers. Cone beam CT systems use less radiation than traditional CT; they are compact and affordable and can be used in a wide range of facilities.
Carestream is exploring the benefits of CBCT technology for capturing images of patient extremities including weight-bearing images of knees, legs and feet, which are of particular interest to orthopedic and sports medicine specialists. (The CBCT system used in this study is investigational and not available for commercial sale).
“We are expanding our proven expertise in radiology with new systems and research aimed at addressing unmet needs in the orthopedic markets,” said Jianqing Bennett, President, Digital Medical Solutions, Carestream. “Our development staff is working with clinical experts and leading healthcare providers to develop new features and functionality that enhance patient imaging in these areas.”
www.carestream.com

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:42Patient studies underway for CBCT

Easing ‘phantom limb’ pain

, 26 August 2020/in E-News /by 3wmedia

Amputees sometimes experience shooting pains or burning sensations in limbs that are no longer there. These sensations seem to originate in the spinal cord and brain, perhaps because neural pathways are receiving mixed signals that something is not right.

A clinical trial by Emory Saint Joseph

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:50Easing ‘phantom limb’ pain

Xbox Kinects could be used in the future to assess the health of patients with conditions such as cystic fibrosis.

, 26 August 2020/in E-News /by 3wmedia

Xbox Kinects could be used in the future to assess the health of patients with conditions such as cystic fibrosis.

Normally found in the hands of gamers rather than medics the Microsoft sensors could be used to assess the respiratory function of patients.

In tests it has proven to be as accurate as a patient breathing into a spirometer – the current method used – but providing additional information about the movement of the chest, which could help in identifying numerous respiratory problems.

University of Warwick
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:37Xbox Kinects could be used in the future to assess the health of patients with conditions such as cystic fibrosis.

Common shoulder dislocation can heal just as well without surgery

, 26 August 2020/in E-News /by 3wmedia

Acromio-clavicular joint dislocation is one of the most common shoulder injuries orthopedic surgeons treat. Severe dislocations are often treated with surgery, but patients who opt for non-surgical treatment typically experience fewer complications and return to work sooner, according to new research.
The AC joint is located at the top of the shoulder between the collarbone and top of the shoulder blade. The AC joint is most commonly injured during sports, but can also be caused by motor vehicle accidents or falls.
For minor AC joint dislocations, surgeons often suggest patients wear a sling for a few weeks and undergo physiotherapy, rather than undergo surgery using a plate and screws.

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:45Common shoulder dislocation can heal just as well without surgery

Primordial goo used to improve implants

, 26 August 2020/in E-News /by 3wmedia

CSIRO has developed an innovative new coating that could be used to improve medical devices and implants, thanks to a

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:53Primordial goo used to improve implants

New neuroimaging method better identifies epileptic lesions

, 26 August 2020/in E-News /by 3wmedia

Epilepsy affects more than 65 million people worldwide. One-third of these patients have seizures that are not controlled by medications. In addition, one-third have brain lesions, the hallmark of the disease, which cannot be located by conventional imaging methods. Researchers at the Perelman School of Medicine at the University of Pennsylvania have piloted a new method using advanced non-invasive neuroimaging to recognize the neurotransmitter glutamate, thought to be the culprit in the most common form of medication-resistant epilepsy.
Glutamate is an amino acid which transmits signals from neuron to neuron, telling them when to fire. Glutamate normally docks with the neuron, gives it the signal to fire and is swiftly cleared. In patients with epilepsy, stroke and possibly ALS, the glutamate is not cleared, leaving the neuron overwhelmed with messages and in a toxic state of prolonged excitation.
In localization-related epilepsy, the most common form of medication-resistant epilepsy, seizures are generated in a focused section of the brain; in 65 percent of patients, this occurs in the temporal lobe. Removal of the seizure-generating region of the temporal lobe, guided by preoperative MRI, can offer a cure. However, a third of these patients have no identified abnormality on conventional imaging studies and, therefore, more limited surgical options.
‘Identification of the brain region generating seizures in location-related epilepsy is associated with significantly increased chance of seizure freedom after surgery,’ said the new study’s lead author, Kathryn Davis, MD, MSTR, an assistant professor of Neurology at Penn. ‘The aim of the study was to investigate whether a novel imaging method, developed at Penn, could use glutamate to localize and identify the epileptic lesions and map epileptic networks in these most challenging patients.’
‘We theorized that if we could develop a technique which allows us to track the path of and make non-invasive measurements of glutamate in the brain, we would be able to better identify the brain lesions and epileptic foci that current methods miss,’ said senior author Ravinder Reddy, PhD, a professor of Radiology and director of Penn’s Center for Magnetic Resonance and Optical Imaging.
Reddy’s lab developed the glutamate chemical exchange saturation transfer (GluCEST) imaging method, a very high resolution magnetic resonance imaging contrast method not available before now, to measure how much glutamate was in different regions of the brain including the hippocampi, two structures within the left and right temporal lobes responsible for short- and long-term memory and spatial navigation and the most frequent seizure onset region in adult epilepsy patients.
The study tested four patients with medication-resistant epilepsy and 11 controls. In all four patients, concentrations of glutamate were found to be higher in one of the hippocampi, and confirmatory methods (electroencephalography and magnetic resonance spectra) verified independently that the hippocampus with the elevated glutamate was located in the same hemisphere as the epileptic focus/lesion. Consistent lateralization to one side was not seen in the control group.

Penn Medicinehttp://tinyurl.com/jrbr5se

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:31New neuroimaging method better identifies epileptic lesions

Seismic for the spine: vibration technology offers alternative to MRI

, 26 August 2020/in E-News /by 3wmedia

Magnetic resonance image isn

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:39Seismic for the spine: vibration technology offers alternative to MRI

New touchless device makes earlier detection of heart problems possible

, 26 August 2020/in E-News /by 3wmedia

Researchers at the University of Waterloo have developed a revolutionary system for monitoring vital signs that could lead to improved detection and prevention of some cardiovascular issues, as well as greater independence for older adults.

Using patent-pending technology called Coded Hemodynamic Imaging, the device is the first portable system that monitors a patient’s blood flow at multiple arterial points simultaneously and without direct contact with the skin. It is ideal for assessing patients with painful burns, highly contagious diseases, or infants in neonatal intensive care whose tiny fingers make traditional monitoring difficult.

‘Traditional systems in wide use now take one blood pulse reading at one spot on the body. This device acts like many virtual sensors that measure blood flow behaviour on various parts of the body. The device relays measurements from all of these pulse points to a computer for continuous monitoring,’ said Robert Amelard, a PhD candidate in systems design engineering at Waterloo and recipient of the prestigious Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada. ‘By way of comparison, think of measuring the traffic flow across an entire city rather than through one intersection.’

Continuous data collection at different parts of the body provides a more complete picture of what

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:48New touchless device makes earlier detection of heart problems possible
Page 153 of 229«‹151152153154155›»

Latest issue of International Hospital

April 2024

16 May 2025

Mindray launches premium ultrasound system to enhance diagnostic capabilities

15 May 2025

World’s first personalised CRISPR therapy treats child with rare metabolic disorder

14 May 2025

Embedded therapist significantly reduces ICU nurse burnout

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription